Lidia Oostvogels

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

Human vaccines & immunotherapeutics

Vaccines

CureVac AG

Rijksuniversiteit Gent (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CureVac AG Mar 01 2018

Germany

VP Clinical Development Prophylactic Vaccines :: Clinical development

GSK Vaccines - Feb 28 2018

Belgium

Clinical and Epidemiology Project Lead :: Clinical R&D

Education History

Rijksuniversiteit Gent

Belgium

PHD

Publications

Olaf-Oliver Wolz, Dominik Vahrenhorst, Gianluca Quintini, Christina Lemberg, Sven D Koch, Sarah-Katharina Kays, Lisa Walz, Neeraja Kulkarni, Michael Fehlings, Peter Wengenmayer, Jana Heß, Lidia Oostvogels, Sandra Lazzaro, Philipp von Eisenhart-Rothe, Philipp Mann
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity. Vaccines 12 (4) (2024)
Olaf-Oliver Wolz, Dominik Vahrenhorst, Gianluca Quintini, Christina Lemberg, Sven D Koch, Sarah-Katharina Kays, Lisa Walz, Neeraja Kulkarni, Michael Fehlings, Peter Wengenmayer, Jana Heß, Lidia Oostvogels, Sandra Lazzaro, Philipp von Eisenhart-Rothe, Philipp Mann
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity. Vaccines 12 (4) (2024)
Edward A Stadtmauer, Keith M Sullivan, Mohamed El Idrissi, Bruno Salaun, Aránzazu Alonso Alonso, Charalambos Andreadis, Veli-Jukka Anttila, Adrian Jc Bloor, Raewyn Broady, Claudia Cellini, Antonio Cuneo, Alemnew F Dagnew, Emmanuel Di Paolo, HyeonSeok Eom, Ana Pilar González-Rodríguez, Andrew Grigg, Andreas Guenther, Thomas C Heineman, Isidro Jarque, Jae-Yong Kwak, Alessandro Lucchesi, Lidia Oostvogels, Marta Polo Zarzuela, Anne E Schuind, Thomas C Shea, Ulla Marjatta Sinisalo, Filiz Vural, Lucrecia Yáñez, Pierre Zachée, Adriana Bastidas
Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice. Human vaccines & immunotherapeutics (2021)
Romulo Colindres, Valentine Wascotte, Alain Brecx, Christopher Clarke, Caroline Hervé, Joon-Hyung Kim, Myron J Levin, Lidia Oostvogels, Toufik Zahaf, Anne E Schuind, Anthony L Cunningham
Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials. Human vaccines & immunotherapeutics 16 (11) (2020)
Desmond Curran, Melissa K Andrew, Myron J Levin, Elisa Turriani, Sean Matthews, Charles Fogarty, Nicola P Klein, Katrijn Grupping, Lidia Oostvogels, Kenneth E Schmader
Evaluation of two frailty indices, with practical application in a vaccine clinical trial. Human vaccines & immunotherapeutics 15 (12) (2019)
Lidia Oostvogels, Thomas C Heineman, Robert W Johnson, Myron J Levin, Janet E McElhaney, Peter Van den Steen, Toufik Zahaf, Alemnew F Dagnew, Roman Chlibek, Javier Diez-Domingo, Iris S Gorfinkel, Caroline Hervé, Shinn-Jang Hwang, Hideyuki Ikematsu, George Kalema, Himal Lal, Shelly A McNeil, Tomas Mrkvan, Karlis Pauksens, Jan Smetana, Daisuke Watanabe, Lily Yin Weckx, Anthony L Cunningham
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials. Human vaccines & immunotherapeutics 15 (12) (2019)

Lidia Oostvogels.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lidia Oostvogels